| 摘要 |
FIELD: chemistry.SUBSTANCE: invention relates to biotechnology, namely to isolated amniotic adhesive human cell, to population and composition, which contain such cells, as well as to methods of obtaining such cells and methods of applying said cells in treatment of individuals. Said cell is adhesive to plastic for tissue cultures. Said cell is OCT-4 (octamer-binding protein 4) by RT-PCR. Said cell represents CD49f, CD90and HLA-Gby flow cytometry data. Said cell is angiogenic.EFFECT: claimed invention makes it possible to obtain novel angiogenic isolated amniotic adhesive human cell.31 cl, 18 dwg, 8 tbl, 6 ex |
| 申请人 |
ANTRODZHENEZIS KORPOREJSHN |
发明人 |
EHBBOT, STJUART;EHDINDZHER, DZHEJMS, U.;FRANKI, ALEKSANDAR;KAPLUNOVSKIJ, ALEKSANDR;JANKOVICH, VLADIMIR;LABATSTSO, KRISTEN;LO, EHRIK;PADLIJA, NIRAV D.;PAREDES, DZHENIFER;VAN, TSZJA-LUN' |
